Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Abstract

Lenalidomide plus dexamethasone is more effective than high-dose dexamethasone alone in relapsed or refractory multiple myeloma. (ClinicalTrials.gov number, NCT00424047 [ClinicalTrials.gov].).